top
Search terms
Results 1 - 10 of 77 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 8
Romanianjournal

Nor is it clear if SES has contributed to the persistent ethnic differences in both US and UK studies of CHD mortality although other factors appear also to be im­portant. [...]AfricanAmerican ...

Date : 08/07/2016
Escardio

14:00 P4748 Incremental value of using NT pro-BNP and cystatin C as predictors of adverse events in low and intermediate risk patients presenting to Emergency Department with chest pain Shiny ...

Poster session 6: Cardiovascular risk; markers and techniques

Date : 30/08/2011 Item size : 283034 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Prevention is better that cure As Niccolo Machiavelli already pointed out in his seminal work Il Principe in 1513, any disease is ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/05/2015
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/09/2015
Ehjcardiovascrec

The results of the HOPE (Heart Outcomes Prevention Evaluation) trial caused much excitement when they were announced in 2000;3 HOPE was the first study to investigate the effects of ACE inhibition in ...

Cardiovascular Research, EDITORIALS: SPOTLIGHT ON LANDMARK PAPERS IN, Roberto Ferrari, Claudio Ceconi

Date : 01/11/2012
Ehjcardiovascrec

A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors Abstract Peripheral vascular disease (PVD) ...

Cardiovascular Research, Review, Koon-Sung Cheng, Dimitri P. Mikhailidis, George Hamilton, Alexander M. Seifalian

Date : 01/06/2002
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

Abstract Aims The success in achieving treatment goals for cardiovascular risk factors in primary care is largely unknown. [...]the goals of this study were (i) to assess whether routinely collected ...

European Heart Journal, Geller, Johann Christoph, Cassens, Sven, Brosz, Mathias, Keil, Ulrich, Bernarding, Johannes, Kropf, Siegfried, Bierwirth, Ralph A., Lippmann-Grob, Bernhard, Schultheiss, ...

Date : 01/12/2007
Ehjournal

Initially cloned from an activated macrophage cell line, GDF-15 has been proposed as a cell death promoter in several tumour cell lines, highlighting its potential role as an inductor of apoptosis in ...

European Heart Journal, Taddei, Stefano, Virdis, Agostino

Date : 01/05/2010
Ehjournal

Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study Aims ...

European Heart Journal, Schnabel, Renate, Rupprecht, Hans J., Lackner, Karl J., Lubos, Edith, Bickel, Christoph, Meyer, Jürgen, Münzel, Thomas, Cambien, François, Tiret, Laurence, ...

Date : 01/02/2005 Item size : 219198 bytes